Champix® (varenicline tartrate) is changing
Champix® has been helping New Zealanders attempt to quit smoking over the past decade.2
Change is now coming.
From 12 December 2018, the Champix® brand name will be replaced by Varenicline Pfizer.1
This change will only affect New Zealand.
Along with the change in brand name, the packaging format will also be simplified.
The dosing regimen will remain unchanged.
With Varenicline Pfizer, there are three ways you can help your patients attempt to quit smoking:2
· 12 week fixed quit* – for patients who want to quit now
· 12 week flexible quit* – for patients who want to quit soon
· 24 week gradual quit – for patients who are not willing or able to quit abruptly
*For patients that have successfully stopped smoking at the end of 12 weeks, an additional 12-week course is recommended to further increase the likelihood of long-term abstinence. Please refer to the Data Sheet for full details.2